2021
DOI: 10.1111/jgh.15469
|View full text |Cite
|
Sign up to set email alerts
|

Long‐term risk of end‐stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan

Abstract: Background and Aim: Chronic hepatitis C virus (HCV) infection is associated with impaired renal function. The aim of this study is to explore the risk of and factors associated with end-stage renal diseases (ESRD) under maintenance dialysis among HCV patients after anti-HCV therapy. Methods: A total of 12 696 HCV-infected patients with interferon-based therapy, including 9679 (76.2%) achieving sustained virological response (SVR), were enrolled from 23 hospitals in Taiwan. Results: During a mean follow-up peri… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 36 publications
0
2
0
Order By: Relevance
“…The achievement of SVR significantly reduces 76% of the risk of ESRD 9 . Nevertheless, another larger nationwide cohort including 12 696 CHC patients receiving interferon‐based therapy (T‐COACH) in Taiwan did not observe a decrease in the incidence of ESRD in SVR patients compared with non‐SVR ones after a longer and greater person‐years follow‐up 10 . The index event, ESRD, in both studies was rare.…”
mentioning
confidence: 81%
See 1 more Smart Citation
“…The achievement of SVR significantly reduces 76% of the risk of ESRD 9 . Nevertheless, another larger nationwide cohort including 12 696 CHC patients receiving interferon‐based therapy (T‐COACH) in Taiwan did not observe a decrease in the incidence of ESRD in SVR patients compared with non‐SVR ones after a longer and greater person‐years follow‐up 10 . The index event, ESRD, in both studies was rare.…”
mentioning
confidence: 81%
“…9 Nevertheless, another larger nationwide cohort including 12 696 CHC patients receiving interferon-based therapy (T-COACH) in Taiwan did not observe a decrease in the incidence of ESRD in SVR patients compared with non-SVR ones after a longer and greater person-years followup. 10 The index event, ESRD, in both studies was rare. The discrepant results between the two studies may in part due to the different patient characteristics.…”
mentioning
confidence: 85%